MAMustafa Atasoy

Mustafa Atasoy

*This is an algorithmically generated author record based on publicly available information.

Mustafa Atasoy has a total of 222 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • What is This Dermatological Disease?

    by Ömer Faruk Elmas, Abdullah Demirbaş, Asuman Kilitci, Mustafa Atasoy

    Dermoscopy is a non-invasive technique, which is increasingly used in the diagnosis of many dermatological diseases. Dermoscopy may be a helpful tool in the diagnostic process of the subacute cutaneous lupus erythematosus (SCLE). Dermatoscopy of SCLE has been reported in several cases. Dermatoscopic examination may provide helpful clues in differentiating SCLE from other differential diagnoses including pityriasis rosea, psoriasis, granuloma annulare, and mycosis fungoides.

  • Prediction of treatment efficacy in psoriasis vulgaris using dermoscopic and capillaroscopic findings: a prospective cohort study

    by Muhammet Resat Akkus, Kemal Ozyurt, Mustafa Atasoy, Ragip Ertas, Huzeyfe Kulu, Sinem Sogancioglu Ozata, Abdullah Demirbas, Omer Faruk Elmas, Esin Diremsizoglu

    Introduction Psoriasis is a chronic inflammatory skin disorder affecting millions worldwide. Dermoscopy and proximal nailfold capillaroscopy have emerged as valuable tools for understanding the pathophysiology and treatment response of psoriasis lesions. Objectives This study aimed to contribute to the limited literature on using dermoscopic findings to detect treatment effectiveness in patients with psoriasis vulgaris. Methods This prospective, single-blinded, observational cohort study included 101 patients aged 18–71 years diagnosed with psoriasis vulgaris who initiated or altered systemic treatment. Monthly dermoscopic and capillaroscopic evaluations were performed alongside assessments of Psoriasis Area Severity Index (PASI), Body Surface Area (BSA), and Dermatology Life Quality Index (DLQI) scores. Results A significant relationship was found between first-month dermoscopic findings and third-month severity scores (PASI, BSA, DLQI). Patients with positive treatment responses exhibited changes from baseline regular capillary dilations to hemorrhagic spots or the absence of vascular findings during the first month. The correlations between dermoscopic changes and severity scores evolved over time, becoming stronger in the second and third months. Nailfold capillaroscopy findings at the third month of treatment showed significant differences from baseline. Conclusions Dermoscopy is a fast, practical, and inexpensive tool for early prediction of treatment effectiveness in psoriasis vulgaris. The disappearance of regular capillary dilations or their change to hemorrhagic spots suggests treatment efficacy, while their persistence indicates poor treatment response. Early detection of treatment effectiveness using dermoscopic findings can facilitate timely adjustments, improving patient outcomes and reducing unnecessary treatment exposure.


  • Open Access

    A determination of the quality of life of patients with vitiligo using the dermatological life quality index

    by Erdal Pala, Mustafa Atasoy

    Background/aims: Vitiligo is a severe skin disease that significantly affects individuals’ quality of life due to striking color changes in external appearance, and one that causes the majority of patients to feel stigmatized. This study was conducted to determine the effects of vitiligo on patients’ psychological and social lives and to elucidate how they perceive the disease. Methods: The research was conducted as an epidemiological study. The Dermatological Life Quality Index (DLQI) was applied to patients with vitiligo presenting to our clinic and to a control group. Results: Fifty patients with vitiligo and 50 healthy individuals were enrolled. The vitiligo group consisted of 26 (52%) women and 24 (48%) men, and the healthy control group of 24 (48%) women and 26 (52%) men. The patients’ mean age was 37.2 ± 13.1 years, and that of the healthy controls 34.7 ± 9.2 years. (p=0.2). No significant age or sex differences were observed between the patient and control groups (p=0.2 and p<0.05, respectively). The mean duration of the disease was 83.9 ± 72.9 months. The most common vitiligo subtype was focal vitiligo, at 52%. The vitiligo and control groups’ mean DLQI scores were 5.5 ± 5.0 and 1.4 ± 1.3, respectively, the difference being statistically significant (p<0.05) Conclusion: The findings of this study show that the quality of life of the patients with vitiligo was significantly impaired compared to the control group.

  • Open Access

    Assessing Latent Tuberculosis Infection Prior to Biologic Therapy in Psoriasis: A New Diagnostic Approach with an Online Interpreter

    by Zuhal Meti̇n, Kemal Özyurt, Mustafa Atasoy, Efşan Gürbüz YONTAR, Ragıp ERTAŞ, Ozkan Gorgulu

    Purpose: The use of biological agents, particularly anti-TNF-alpha treatments, is associated with an elevated risk of tuberculosis (TB). Hence, a comprehensive assessment of latent tuberculosis infection (LTBI) before biologic therapies is imperative. The objective of this study was to evaluate the utility of an online tuberculin skin test (TST)/ interferon-γ release assay (IGRA) interpreter (OI-TST/IGRA) in assessing the risk of LTBI prior to initiating biological therapies in psoriasis patients. Materials and methods: 116 psoriasis patients who were previously evaluated for TB by a pulmonologist before being treated with a biologic agent were re-evaluated retrospectively with OI-TST/IGRA (tstin3d.com). Mean positive predictive value (PPV), mean annual risk of development of active tuberculosis (ARDATB), and mean cumulative risk of active tuberculosis (CRATB) values were calculated with OI-TST/IGRA and compared with previous results. Chi-square, Fisher-Freeman-Halton exact tests, Cohen's Kappa, and Mann-Whitney U-test were used in comparisons of groups. Results: The PPV of the LTBI-positive group was significantly higher than the LTBI-negative group. The PPV, ARDATB and CRATB values of the TST size of >15 mm group were significantly higher than the TST size of 5-9 mm and TST size of 10-15 mm groups. The PPV, ARDATB, and CRATB values of the QuantiFERON-TB Gold In-tube test (QFT-GIT)-positive group were significantly higher than the QFT-GIT-negative group. And the same values of the chest X-ray (CXR)-positive group were significantly higher than the CXR-negative group. The PPV, ARDATB, and CRATB values were positively correlated with QFT-GIT and CXR results. In addition, the PPV was positively correlated with previous LTBI decisions and TSTs. Conclusion: OI-TST/IGRA in which many factors are questioned and PPV, ARDATB, and CRATB values are evaluated together, may be a valuable tool for assessing the risk of active TB in psoriasis patients and preventing overdiagnosis and unnecessary prophylaxis.


  • In Chronic Spontaneous Urticaria, Complete Response to Antihistamine Treatment Is Linked to Low Disease Activity

    by Murat Türk, Ragıp Ertaş, Ümit Murat Şahiner, Pavel Kolkhir, Bülent Enis Şekerel, Özge Soyer, Atıl Avcı, Mustafa Atasoy, Kemal Özyurt, Yekta Türk, et al.

    Introduction: The use of predictors of response to a specific treatment in patients with chronic spontaneous urticaria (CSU) can improve disease management, help prevent unnecessary healthcare costs, and save time. In this study, we aimed to identify predictors of complete response to standard-dosed and higher than standard-dosed antihistamine treatments in patients with CSU. Methods: Medical records of 475 CSU patients, 120 of them Results: CSU disease activity, which was assessed by urticaria activity score (UAS), was the only clinical parameter that predicted complete response to standard-dosed and higher than standard-dosed antihistamine treatment, with ML models and traditional statistics, for all age groups. Based on ROC analyses, optimal cut-off values of disease activity to predict complete response were UAS p = 0.001) and higher than standard-dosed (AUC = 0.79; p = 0.001) antihistamine treatments, respectively. Also, ML models identified lower total IgE (Discussion: In this study, we showed that patients with UAS <3 are highly likely to have complete response to standard-dosed AH and those with a UAS <4 are highly likely to have complete response to higher than standard-dosed AH treatment. Low CSU disease activity is the only universal predictor of complete response to AH treatment with both ML models and traditional statistics for all age groups.


  • Open Access

    The relationship between hidradenitis suppurativa and irritable bowel syndrome: a cross-sectional study

    by Abdullah Demi̇rbaş, Ömer Faruk Elmas, Hedi̇ye Eker, Gözde Ulutaş Demi̇rbaş, Recep Dursun, Mustafa Atasoy, Ümi̇t Türsen, Torello Lotti̇

    Background/aim: Irritable bowel syndrome (IBS) is a functional gastrointestinal disorder in which one experiences abdominal pain, tension, cramping, bloating, and changes in the form and frequency of defecation, without an underlying organic disease. Many skin diseases have been reported to be more common in people with functional bowel disease. To our knowledge, however, no previous study investigated the potential relationship between hidradenitis suppurativa (HS) and IBS. In this study, we aimed to examine the potential association between IBS and HS. Materials and methods: Patients with HS and healthy subjects were enrolled in this cross-sectional study. All participants were assessed for the presence of IBS. ROME IV criteria were used to identify IBS cases. Hurley staging, modified Sartorius score, and physician's global assessment score were applied to define clinical severity and staging of HS. Results: According to the Rome IV diagnostic criteria, 54 (67.50%) of 80 HS patients and 23 (28.75%) of 80 control group were diagnosed with IBS. The frequency of IBS was statistically significantly higher in the patient group than in the control group (P < 0.001). No statistically significant difference was found between the two groups in terms of abnormal stool frequency and family history of IBS (P = 0.28, P = 0.862, respectively). Abnormal stool form, mucus in stool, abdominal distension, feeling of incomplete evacuation were statistically significantly higher in HS patients compared to the controls (P = 0.01, P = 0.02, P < 0.001, P = 0.001, respectively). Conclusion: Our study revealed that there might be a potential link between HS and IBS.


  • Clinical, Demographic and Treatment Characteristics of Pediatric Psoriasis: A Multicenter Study of 150 Patients

    by Abdullah Demirbaş, Kemal Özyurt, Ömer Faruk Elmas, Mahmut Sami Metin, Mustafa Atasoy, Ümit Türsen, Asuman Kilitci, Torello Lotti


  • A novel marker of systemic inflammation in psoriasis and related comorbidities: chitotriosidase

    by Bilal İlanbey, Ömer Faruk Elmas, Eser Yıldırım Sözmen, Ümran Günay, Abdullah Demi̇rbaş, Mustafa Atasoy, Ümit Türsen, Torello Lotti̇

    Background/aim: Chitotriosidase (ChT) is an enzyme secreted by activated macrophages and neutrophils in response to proinflammatory signals. There is growing evidence indicating that ChT activity reflects the systemic inflammatory status. This study aimed to investigate whether serum ChT activity increased in patients with psoriasis and related comorbidities. Materials and methods: This cross-sectional study included 53 (28 with associated comorbidities and 25 without comorbidities) patients with psoriasis and 52 healthy volunteers. All participants underwent laboratory investigations for serum ChT levels, complete blood count, erythrocyte sedimentation rate, C-reactive protein, and serum lipid levels. Results: The patients with psoriasis showed significantly higher levels of ChT activity as compared to the healthy controls (23.5 +/- 11.4 vs. 17.5 +/- 10.4 mu mol/mL/hour; p = 0.015). Additionally, the ChT activity was significantly higher in patients with comorbidities than in those without (p = 0.042). Conclusion: Our data support the pathogenetic role of inflammatory processes induced by macrophage activation in patients with psoriasis and related comorbidities. We believe that high ChT activity in patients with psoriasis may serve as an early prediction of the possible related comorbidities.


  • Favipiravir ile Başarılı Şekilde Tedavi Edilen Pemfiguslu bir COVID-19 Vakası

    by Abdullah Demi̇rbaş, Ömer Faruk Elmas, Mustafa Atasoy, Gözde Ulutaş Demi̇rbaş, Ümit Türsen, Torello Lotti, Asuman Ki̇li̇tci̇

    COVID-19 is not only a respiratory disease, but a multisystem disease that can cause organ dysfunction and coagulation disorder associated with high mortality and morbidity, particularly in vulnerable populations. Severe complications can be seen especially in elderly patients with systemic disease and immunosuppressive patients. We present the case of COVID-19 that developed in a 38-year-old female patient with pemphigus successfully managed with favipiravir. COVID-19 sadece bir solunum hastalığı değil, aynı zamanda özellikle hassas popülasyonda yüksek mortalite ve morbidite ile ilişkili organ disfonksiyonuna ve pıhtılaşma bozukluğuna neden olabilen multisistemik bir hastalıktır. Özellikle sistemik hastalığı olan yaşlı hastalarda ve immünsüpresif hastalarda ciddi komplikasyonlar görülebilmektedir. Favipiravir ile başarılı bir şekilde tedavi edilen pemfiguslu 38 yaşındaki bir kadın hastada gelişen COVID-19 vakasını sunuyoruz.


  • Open Access

    Therapeutic efficacy and safety of three different modalities in pediatric patients with plantar warts

    by Emine Müge Acar, Belkız Uyar, Ömer Faruk Elmas, Kemal Özyurt, Mustafa Atasoy, Ümit Türsen, Torello Lotti

    Human papillomavirus infection is relatively common in communities. Thus, determining an effective and painless treatment method, especially in pediatric patients is of utmost importance. This study aimed to compare the outcomes of three different methods of treating plantar warts in pediatric patients. Children with verruca plantaris treated with a salicylic acid–lactic acid combination once daily (SA/LA 1), a salicylic acid–lactic acid combination applied in three to seven layers under occlusion every 3 days (SA/LA 2), or a combination of 5-fluorouracil (0.5%) and salicylic acid (10%) (SA/5-FU) were evaluated retrospectively. Treatment responses and recurrence rates were also evaluated after a minimum of 4 months. Among the 98 children with verruca plantaris, 19 were treated with SA/LA 1, 53 were treated with SA/LA 2, and 18 were treated with SA/5-FU; the eight patients who received cryotherapy were excluded. The mean treatment duration was significantly shorter in the SA/LA 2 group than in the SA/LA 1 group and the SA/5-FU group. (p = 0.000 for both) Application of a salicylic acid–lactic acid combination in multiple layers under occlusion is a safe, painless, and effective treatment method for plantar warts in children.